BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36753806)

  • 1. Tissue-resident memory T cells in the multiple sclerosis brain and their relationship to Epstein-Barr virus infected B cells.
    Serafini B; Rosicarelli B; Veroni C; Aloisi F
    J Neuroimmunol; 2023 Mar; 376():578036. PubMed ID: 36753806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
    Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBV infected cells in the multiple sclerosis brain express PD-L1: How the virus and its niche may escape immune surveillance.
    Serafini B; Benincasa L; Rosicarelli B; Aloisi F
    J Neuroimmunol; 2024 Apr; 389():578314. PubMed ID: 38422689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.
    Serafini B; Rosicarelli B; Franciotta D; Magliozzi R; Reynolds R; Cinque P; Andreoni L; Trivedi P; Salvetti M; Faggioni A; Aloisi F
    J Exp Med; 2007 Nov; 204(12):2899-912. PubMed ID: 17984305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation.
    Serafini B; Severa M; Columba-Cabezas S; Rosicarelli B; Veroni C; Chiappetta G; Magliozzi R; Reynolds R; Coccia EM; Aloisi F
    J Neuropathol Exp Neurol; 2010 Jul; 69(7):677-93. PubMed ID: 20535037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.
    Veroni C; Aloisi F
    Front Immunol; 2021; 12():665718. PubMed ID: 34305896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.
    Willis SN; Stadelmann C; Rodig SJ; Caron T; Gattenloehner S; Mallozzi SS; Roughan JE; Almendinger SE; Blewett MM; Brück W; Hafler DA; O'Connor KC
    Brain; 2009 Dec; 132(Pt 12):3318-28. PubMed ID: 19638446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus in multiple sclerosis.
    Bagert BA
    Curr Neurol Neurosci Rep; 2009 Sep; 9(5):405-10. PubMed ID: 19664371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis.
    Magliozzi R; Serafini B; Rosicarelli B; Chiappetta G; Veroni C; Reynolds R; Aloisi F
    J Neuropathol Exp Neurol; 2013 Jan; 72(1):29-41. PubMed ID: 23242282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes.
    Pender MP; Csurhes PA; Pfluger CM; Burrows SR
    BMC Neurol; 2011 Aug; 11():95. PubMed ID: 21810280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis.
    Veroni C; Serafini B; Rosicarelli B; Fagnani C; Aloisi F
    J Neuroinflammation; 2018 Jan; 15(1):18. PubMed ID: 29338732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter lesions in multiple sclerosis are enriched for CD20
    Hsiao CC; Fransen NL; van den Bosch AMR; Brandwijk KIM; Huitinga I; Hamann J; Smolders J
    Eur J Immunol; 2021 Feb; 51(2):483-486. PubMed ID: 32949467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.
    Fernández-Menéndez S; Fernández-Morán M; Fernández-Vega I; Pérez-Álvarez A; Villafani-Echazú J
    J Neurol Sci; 2016 Feb; 361():213-9. PubMed ID: 26810546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.
    Pender MP; Csurhes PA; Lenarczyk A; Pfluger CM; Burrows SR
    J Neurol Neurosurg Psychiatry; 2009 May; 80(5):498-505. PubMed ID: 19015225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions.
    Fransen NL; Hsiao CC; van der Poel M; Engelenburg HJ; Verdaasdonk K; Vincenten MCJ; Remmerswaal EBM; Kuhlmann T; Mason MRJ; Hamann J; Smolders J; Huitinga I
    Brain; 2020 Jun; 143(6):1714-1730. PubMed ID: 32400866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Massive intracerebral Epstein-Barr virus reactivation in lethal multiple sclerosis relapse after natalizumab withdrawal.
    Serafini B; Scorsi E; Rosicarelli B; Rigau V; Thouvenot E; Aloisi F
    J Neuroimmunol; 2017 Jun; 307():14-17. PubMed ID: 28495131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
    Sargsyan SA; Shearer AJ; Ritchie AM; Burgoon MP; Anderson S; Hemmer B; Stadelmann C; Gattenlöhner S; Owens GP; Gilden D; Bennett JL
    Neurology; 2010 Apr; 74(14):1127-35. PubMed ID: 20220124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus and multiple sclerosis.
    Salvetti M; Giovannoni G; Aloisi F
    Curr Opin Neurol; 2009 Jun; 22(3):201-6. PubMed ID: 19359987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
    Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA
    Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins.
    van Nierop GP; Mautner J; Mitterreiter JG; Hintzen RQ; Verjans GM
    Mult Scler; 2016 Mar; 22(3):279-91. PubMed ID: 26041797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.